RAAB MICHAEL — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

RAAB MICHAEL has filed 5 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $2.77M.

Profile

Michael Raab is an executive in the biopharmaceutical industry, currently serving as President and CEO of Ardelyx, Inc. He has held various roles including Director and President at Amicus Therapeutics, Inc. Raab has been involved in the development of innovative therapies for unmet medical needs.

Board memberships

• Ardelyx, Inc.
• Amicus Therapeutics, Inc.

Awards & honors

• Led the development of IBSRELA
• Served as President & CEO at multiple biopharmaceutical companies

Recent Transactions

Companies — Last 90 Days

• ARDELYX, INC. (ARDX) — 4 filings, last 2026-06-17
• AMICUS THERAPEUTICS, INC. (FOLD) — 1 filings, last 2026-04-27

Frequently Asked Questions

Who is RAAB MICHAEL?

Michael Raab is an executive in the biopharmaceutical industry, currently serving as President and CEO of Ardelyx, Inc. He has held various roles including Director and President at Amicus Therapeutics, Inc. Raab has been involved in the development of innovative therapies for unmet medical needs.…

How many SEC Form 4 filings has RAAB MICHAEL submitted recently?

5 primary Form 4 filings in the last 90 days, covering 2 companies.

Has RAAB MICHAEL been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 21 open-market sales ($2.77M) across all tracked filings.

Where can I see all of RAAB MICHAEL's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week